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Abstract
Following exposure to biological milieus (e.g. after systemic administration), nanoparticles (NPs) 
get covered by an outer biomolecular corona (BC) that defines many of their biological outcomes, 
such as the elicited immune response, biodistribution, and targeting capabilities. In spite of this, 
the BC role in regulating the cellular uptake and the subcellular trafficking properties of NPs has 
remained elusive. Here, we tackle this issue by employing multicomponent (MC) lipid NPs, 
human plasma (HP) and HeLa cells as models for nanoformulation, biological fluid, and target cell 
(respectively). By confocal fluorescence microscopy experiments and image correlation analyses, 
we quantitatively demonstrate that the BC promotes a neat switch of cell entry mechanism and 
subsequent intracellular trafficking, from macropinocytosis to clathrin-dependent endocytosis. 
Nano liquid chromatography tandem mass spectrometry identifies Apolipoproteins as the most 
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(iMSD). Table S1. The full list of the most abundant corona proteins associated with MC liposomes as identified by NanoLC-MS/MS.
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abundant components of the BC tested here. Interestingly, this class of proteins target the LDL 
receptors, which are overexpressed in clathrin-enriched membrane domains. Our results highlight 
the crucial role of BC as an intrinsic trigger of specific NP-cell interactions and biological 
responses and set the basis for a rational exploitation of the BC for targeted delivery.
Graphical abstract
Biomolecular corona promotes a switch of both the cell entry mechanism and the intracellular 
dynamics of liposomes
Introduction
In the last decades, nanoparticle (NP)-based delivery systems have been extensively studied 
and employed for therapeutic purposes with many of the proposed solutions providing safe 
and efficient delivery of pharmaceutical nanoformulations to targeted cells and/or 
tissues.1–7. However, despite recent progresses and great expectations, few nanoformulations 
have reached clinical practice6. Such a wide gap between NP-based systems and advanced 
medicinal products was demonstrated to depend mainly on what occurs to NPs upon contact 
with a physiological environment (e.g. blood, interstitial fluids, saliva etc.).8 Under in vivo 
conditions, NPs get covered by an outer biomolecular corona (BC), which changes their 
“synthetic identity” including size, surface charge, and aggregation state9. It is precisely this 
new identity, usually referred to as “biological identity”, which controls the biological fate of 
NPs, including their circulation time, immune system activation, accumulation in liver and 
spleen, removal from the bloodstream via the mononuclear phagocytic system (MPS), 
biodistribution, and cellular interactions7. Concerning cellular interactions in particular, 
since the function of nanomaterials is expected to be carried out in a specific cellular 
location,10, 11 accurate characterization of BC12 and understanding NP-BC-cell interactions 
is a critical step to design safer and more efficient NPs as well as to predict possible toxicity 
effects13–16. After cellular association, most nanomaterials get internalized via endocytic 
pathways17–19. Some of them, such as clathrin-mediated endocytosis, are regulated by 
activation of transmembrane receptors, which activate intracellular signaling cascades that, 
in turn, control cellular processes such as cellular differentiation, proliferation, and 
survival10. Some other, such as micropinocytosis, entail a series of events initiated by 
extensive plasma membrane reorganization or ruffling to form an external macropinocytic 
structure that is then enclosed and internalized20. It thus appears crucial to understand if BC 
plays a role in mediating the interaction of NPs with cell machinery.
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To fulfill this gap, in this work, we explored cellular uptake, endocytic pathways, and 
intracellular dynamics of NPs in HeLa cells, both in absence and presence of BC from 
human plasma (HP). We used multicomponent (MC) liposomes, in light of their proved high 
performances and potential applicability in a number of diseases17, 21–23. We focused on 
clathrin-mediated endocytosis (CME), caveolin-mediated endocytosis (CAV), and 
macropinocytosis (MCR) and detected significant differences between bare systems and NP-
BC complexes. To date, the most efficient, reliable, and affordable tools for testing 
endocytosis of nanoparticles are two: i) chemical inhibition of internalization24; and ii) 
simultaneous labeling of NPs and endocytic vesicles25. In pharmacological blocking studies 
cells are pretreated with chemical drugs that specifically affect distinct uptake routes and 
intracellular pathways under well-established conditions. However, some drugs may induce 
unpredictable side effects (e.g. alteration of the cellular environment) and efficiency of 
inhibition is not always 100%. On the other hand, fluorescence confocal microscopy allows 
visualizing the intracellular trafficking of fluorescently labeled NPs (e.g. red labeled NPs) in 
living cells in the presence of various endocytic markers (e.g. green dyes). Controversial 
issues have been raised, however, that labeling is not completely specific. In addition, 
defects in uptake of endocytic dyes can give rise to significant background fluorescence. 
Thus, to rule out any possible side effect of these treatments, we previously explored the 
cellular uptake mechanisms of MC cationic liposomes by combining pharmacological and 
imaging tools26. Under optimized experimental conditions (e.g. concentration of chemical 
drugs and endocytic markers etc.) pharmacological and imaging results were in complete 
agreement. Thus, to evaluate the internalization mechanism of MC lipid NPs, we carried out 
fluorescence colocalization studies on two-channel images, then measured overlap and 
correlation of the signals corresponding to NPs and endocytic vesicles. Furthermore, we 
categorized the cytoplasmatic dynamics of the vesicles, by analyzing fluorescence image 
time-series. More precisely, we employed the iMSD method27, i.e., a fluorescence-based 
spatiotemporal fluctuation analysis that makes possible to detect the mode of motion of 
vesicles from imaging, in the form of a mean square displacement (MSD) vs. time-delay 
plot. The usage of fluorescence correlation spectroscopy (FCS) methods is emerging as a 
quantitative measure for following nano-sized objects being transported inside single living 
cells.28
By coupling results from colocalization studies and intracellular dynamics experiments, here 
we claim that the BC is responsible for a switch in the internalization processes of lipid NPs 
and affects their intracellular trafficking mechanisms. Notably, tandem nano liquid 
chromatography (nanoLC) tandem mass spectrometry (MS/MS) identified Apolipoproteins 
as the most abundant components of the BC tested here. Interestingly, Apolipoproteins target 
the LDL receptors, which are the most abundant receptors in clathrin-enriched membrane 
domains. Clearly, results of the present investigation cannot fully account for the complexity 
of the in vivo NP-BC-cellular interactions. To achieve this, comprehensive studies entailing 
libraries of NPs, BCs, and cells will be needed. However, we believe that basic studies like 
this will contribute to the design of specific targeted nanoformulations to exploit specific 
cellular pathways of interest. In this way, many off-target effects could be minimized or even 
fully avoided.
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Results and Discussion
The use of NPs offers effective solutions to a wide range of biomedical issues29. Their entry 
into target cells is a fundamental step towards boosting therapeutic efficacy. Upon contact 
with biological fluids, the surface of NPs is modified by the adsorption of biomolecules 
leading to formation of the so-called BC6. Key interactions are controlled by biomolecules 
residing at the interface between the NP surface and the biological target. Understanding 
how this BC could affect the NP-interactions is more important than studying each entity 
(i.e. NPs and cells) individually7. Detailed knowledge of the parameters regulating these 
interactions could help to manipulate the physiochemical properties of NPs in order to 
dictate selective accumulation in certain locations (e.g. tissues and organs) or to promote 
tunable cellular interactions. Even tough recent research suggests a strong relationship 
between the nature of BC and the NP-cell association13, 14, 30, 31, its precise role in 
regulating cellular uptake and subcellular processes has not been identified yet. The central 
aim of this investigation was therefore to explore the role played by the BC on the cellular 
uptake and intracellular trafficking of NPs.
MC liposomes exhibited significantly greater delivery efficiency in many cell lines as 
compared to commercially available formulations17 and were therefore used as a reference. 
Usually, a preliminary characterization of lipid NPs both before and after exposure to plasma 
proteins provides information about the impact of the BC on the chemical physical 
properties of the employed systems. In this regard, we characterized MC liposomes and MC 
liposome-BC complexes in terms of size and Zeta potential. We found that bare liposomes 
have mean hydrodynamic diameter of 144 ± 4 nm and positive Zeta potential (34.5 ± 1.1 
mV). Following 1-hour exposure to HP, we detected an increase in particle size (178 ± 6 nm) 
and the inversion of surface charge (Zeta potential = − 18 ± 2 mV)1.
Size enlargement is in agreement with the results of recent investigations showing that the 
liposome–BC is roughly 10–40 nm thick depending on the lipid composition32, while 
‘normalization’ of zeta potential has been frequently observed, given that most plasma 
proteins have a net negative charge at physiological pH1. Then, we administered liposomes 
and liposome-BC complexes to HeLa cells to evaluate cytotoxicity and cell uptake by MTT 
assay and flow cytometry, respectively. Results are listed in Table 1. Following 
administration, the percentage of living cells was extremely high for both liposomes and 
liposome-BC complexes. This finding ensured good cytocompatibility of the employed 
systems.
A similar trend was found in the outcomes of flow cytometry analysis, which quantifies the 
cell uptake as percentage of fluorescence cells. Measured values read 99% for bare 
liposomes and 93% for liposome-BC complexes. To investigate the role of BC on the 
cellular uptake and intracellular trafficking of MC liposomes, we applied fluorescence 
microscopy that provides useful tools to quantify spatial distributions of labeled particles 
within living cells and their intracellular motion. By fluorescence colocalization 
experiments, we measured overlap and correlation of the fluorescence signals arising from 
red-labeled particles and green-labeled endocytic vesicles, aiming at elucidating the possible 
impact of the BC on the internalization mechanisms of the employed NPs. Figure 1 shows 
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some representative dual-color images depicting the colocalization of liposomes and 
liposome-BC complexes with endocytic vesicles, corresponding to clathrin-mediated 
endocytosis (CME), caveolae-mediated endocytosis (CAV), and macropinocytosis (MCR). 
Data processing is based on the evaluation of Manders and Pearson’s coefficients (i.e. M1, 
M2, and P, respectively) whose measured values are reported in a comprehensive 3D scatter 
plot (Figure 1 panels D, E, F).
For clarity, the superiority of Manders vs. Pearson’s coefficients is under debate33. As 
establishing a ranking between Manders and Pearson’s coefficients is beyond our scopes, we 
decided to calculate and report all of them. In this representation, each data point 
corresponds to a dual-color image and points belonging to the same class define a specific 
“cluster”, i.e. a multivariate distribution that is uniquely characterized by average and 
covariance matrix. Interestingly, for CME and MCR, the distributions of liposome-BC 
complexes are clearly distinguishable with respect to those of bare liposomes (Figure 1 
panels D, F). Colocalization of liposome-BC complexes with CME-vesicles yields higher 
values of all the coefficients, with respect to their bare counterparts (i.e. pristine MC 
liposomes). Projections along the coordinate axes are reported to compare all the measured 
values of M1 (Figure 1 panel G), M2 (Figure 1 panel H), and P (Figure 1 panel I). Of note, 
this trend is inverted for colocalization experiments with MCR-vesicles. By contrast, 
colocalization with CAV-vesicles yields almost superimposed distributions (Figure 1 panel 
E). Indeed, no significant difference is found for the colocalization parameters of liposome 
and liposome-BC complexes with CAV-vesicles. In summary, confocal imaging inspection 
followed by quantitative colocalization assays clarified that the cell entry of MC liposomes 
occurs mainly through MCR, while both clathrin- and caveolae-mediated endocytosis play a 
minor role in the process. This result is in very good agreement with previous findings by 
some of us17. MCR is a pinocytosis process resulting in the formation of large vesicles of 
irregular size and shape, generated by actin-driven invagination of the plasma membrane10. 
This suggests that the cellular uptake of bare MC liposomes does not involve the utilization 
of lipid rafts or pit-forming proteins. Of note, BC clearly induces a switch in the mechanism 
of internalization of MC liposomes, from MCR to CME. This is noteworthy, as these 
clathrin-enriched domains cover a minor fraction of the cell surface (typically between 0.5–
2%)10. Recently, it became clear that the mechanism of intracellular trafficking of NPs is 
crucial to sort components of the endocytic pathway to a number of subcellular destinations.
Motion characterization at intracellular level requires acquisition and post-processing of 
time series exploring the behavior of the investigated particles at high spatial and temporal 
resolution. In this regard, confocal microscopy and spatiotemporal image correlation 
analysis allowed us to categorize the intracellular dynamics of liposomes and liposome-BC 
complexes.
In detail, we acquired fluorescence image-stacks (technical details are reported in the 
Methods section) and processed them through the iMSD method27 that allowed us to 
categorize the particle mode of motion (Brownian diffusion vs. active transportation) and 
determine the main system’s dynamic parameters, i.e. diffusion coefficient (D) and speed (v) 
of particles. The measured values of D and v for bare Figure 2 panel A, where each data 
point corresponds to an image time-series and ellipses describe the 2D distributions 
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liposomes and liposome-BC complexes are reported in in terms of average values and 
covariance matrices. Distributions are located and oriented in distinct regions of the (D, v)-
space, revealing significant differences between the intracellular dynamics of the 
investigated systems. Particularly, iMSD shows that bare liposomes are actively transported 
in the cytosol, while liposome-BC complexes mainly undergo Brownian diffusion (see 
supplementary Figure S1 for details). Similarly, we carried out iMSD analyses on CME, 
CAV and MCR vesicles. Measured values of the dynamic parameters are reported in Figure 
2 panel B, which depicts the experimental data as 2D multivariate distributions. Dynamics of 
MCR vesicles (mainly active transport) is remarkably different as compared to that of, CME 
(mainly Brownian diffusion). Of note, a global comparison of these outcomes suggests that 
the intracellular dynamics of bare liposomes is similar to that of MCR vesicles as well as the 
motion of liposome-BC complexes resembles that of CME-vesicles, in keeping with 
colocalization results. These trends can be also recognized in the 1D distributions of 
diffusion coefficient (Figure 2 panel C) and particle speed (Figure 2 panel D).
To provide quantitative estimation of this behavior, we compared multivariate distributions 
of NPs and endocytic vesicles in terms of Mahalanobis distance34, 35. The Mahalanobis 
distance, here referred to as λM, is a statistical parameter representing a non-Euclidean 
distance between a data point and a distribution. In the employed representation, λM-values 
anisotropically increase from the average position of the 2D distribution, where λM =0. 
Points on the ellipse have λM =1 and λM >1 outside the ellipse. Notably, the statistical 
significance of the difference between λM = 1 and λM = 2 is the same as that of a data point 
located at σ or 2σ far from the mean value of a normal distribution of variance σ2.
We report in Figure 3 panel A the measured λM between data points corresponding to 
liposomes and the distributions of endocytic vesicles. Results confirm that the dynamic 
parameters of liposomes are located “far” from the distribution of CME-vesicles (maximum 
<λM>=1.95) and “near” that of MCR-vesicles (minimum <λM>=1.01). This trend is 
inverted for liposome-BC complexes (Figure 3 panel B).
In summary, our body of evidence shows that: i) pristine liposomes are mainly internalized 
by MCR and, once inside HeLa cells, their mode of motion resembles that of 
macropinosomes (active transportation); ii) The preferential uptake pathway of liposome-BC 
complexes is CME and their intracellular trafficking is similar to that of CME-vesicles. 
Collectively, our data show that BC triggers favorable interactions of MC liposomes with 
clathrin-coated pits. CME, among others, has the function to regulate the mechanism by 
which cells achieve nutrients and plasma membrane components, such as cholesterol, via 
low-density lipoproteins (LDL) and vesicles containing proteins with receptor binding 
sites10 While clarifying the exact molecular mechanisms regulating the internalization of 
liposome-BC complexes within HeLa cells is beyond the scope of this investigation, our 
findings are likely to suggest that some BC components may favorably interact with receptor 
molecules in turn internalized by CME. To verify this speculation, we characterized the BC 
of MC liposomes by liquid chromatography (LC) tandem mass spectrometry (MS/MS).
Table 2 shows the 25 most abundant proteins identified in the BC (the full list of identified 
proteins is given in Table S1): interestingly, MC liposomes are mainly covered by 
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apolipoproteins (Apo A-I, Apo C−II, Apo E, Apo C−III, Apo A−IV are the most enriched). 
Remarkably, it is well known that Apolipoproteins can be targets of the LDL receptor, which 
in turn is preferentially localized within clathrin-enriched domains36.
ApoA-I and apoE4 are two relevant members of the family of soluble Apolipoproteins. 
While apoA-I is the principal component of high-density lipoprotein (HDL), apoE4 
preferentially binds to very low-density lipoprotein (VLDL). Of note, both ApoA-1 and 
ApoE4 show high affinity for the LDL receptor. Recently, absorption of Apo A-I and ApoE4 
to negatively charged FePt NPs has been investigated37. Of note, the affinity of ApoE4 for 
the particle surface was found to be almost four orders of magnitude higher than that of Apo 
A-I. On the other hand, results reported in Table 2 show that both proteins seem to be 
present on the liposome surface to the same amount. This finding confirms that many factors 
shaping BC exist leading to different BCs. Our suggestion is supported by recent literature 
showing that LDL-enriched NPs present functional motifs that allow recognition by LDL 
receptor38. Our future biological understanding of how NPs interact with cells will confirm 
these conclusions more in depth by benefiting from a detailed knowledge of the 
arrangements of functional motifs of BC components at the nanoscale39–41.
Figure 4 summarizes our present understanding of the role played by BC on the MC 
liposome association with HeLa cells. BC controls the mechanism of NP-cell association 
and directs the cellular uptake via specific internalization pathways, CME in our case. This 
is crucial point, since each internalization route has its own intracellular dynamics (i.e. 
active transport vs. Brownian diffusion) and final fate. Thus, when one designs NPs for 
biomedical applications42 the BC should be carefully considered, since it greatly influences 
the mechanism of cellular uptake. In addition partial conservation of the original BC on the 
nanoparticle surface may play a key role in determining subsequent cellular dynamics43. 
Basic studies like this shall contribute to the design of specific nanodelivery systems to 
exploit specific endocytic pathways of interest. This aspect may have a dramatic application 
in the emerging field of “personalized nanomedicine”44.
Some of us have shown that alterations in concentration and structure of plasma proteins as 
those produced by clinical manifestations of disease lead to formation of “personalized BC” 
(PBC)5, 45. Among other implications, this means that various cell types may employ 
different pathways to internalize NPs with their own PBC. To dictate selective accumulation 
of NPs at the desired target site, comprehensive studies involving libraries of NPs, PBCs, 
and cell lines will be needed. In this way, many off-target effects that typically occur in vivo 
could be minimized or fully prevented.
Materials and Methods
Human Plasma collection
Lyophilized HP was purchased by Sigma-Aldrich (Milan, Italy, P9523 SIGMA) and 
dissolved in 1 mL of ultrapure water. Plasma is the liquid part of the blood and lymphatic 
fluid, which makes up about half of its volume. It is prepared from whole blood that is 
collected with anticoagulants (9:1) and centrifuged to remove cells and cellular debris. 
P9523 SIGMA is prepared from pooled human blood and contains 4% trisodium citrate as 
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an anticoagulant. It is tested for clotting, which implies that the clotting factors are active. 
However, it is not analyzed to control whether other enzymes are native or denatured. Before 
analysis, HP was thawed at 4°C and then warmed at room temperature.
Preparation of liposomes
Cationic lipids (3β-[N-(N′,N′-dimethyl-aminoethane)-carbamoyl])-cholesterol (DC-Chol) 
and 1,2-Dioleoyl-3-trimethyl-ammonium-propane (DOTAP), zwitterionic lipids dioleoyl-
phosphocholine (DOPC) and dioleoyl-phosphatidyl-ethanol-amine (DOPE) were purchased 
from Avanti Polar Lipids (Alabaster, AL) and used without further refinement. For the 
preparation of MC liposomes, DC-Chol, DOTAP, DOPC and DOPE were dissolved in 
chloroform (molar ratios 1:1:1:1) and the solvent was evaporated under vacuum for 2 hours. 
Lipid films were then hydrated with ultrapure water to obtain a final concentration of 1 
mg/ml. Finally, the obtained liposome solutions were extruded 20 times through a 0.1 μm 
polycarbonate filter with an Avanti Mini-Extruder (Avanti Polar Lipids, Alabaster, AL). For 
fluorescence microscopy experiment liposomal formulations were synthesized with the 
addition of Texas red-DOPE (Life Technologies, Carlsbad, CA) (Concentration 7 10−3 
mg/mL; fluorescent lipid/total lipid molar ratio = 5/1000).
Preparation of liposome-BC complexes
MC liposomes-BC complexes were obtained by incubating MC liposomes with human 
plasma (HP) for one h at a fixed ratio of 1:1 v/v.
Characterization of complexes
A preliminary characterization of the complexes has been carried out in terms of 
hydrodynamic radius and zeta potential. All size and zeta potential measurements were 
made on a Zetasizer Nano ZS90 (Malvern, U.K.) equipped with a 5 mW HeNe laser 
(wavelength = 632.8 nm) and a digital logarithmic correlator. All the results are given as 
mean ± standard deviation of three independent replicates.
Cell culture
Human cervical cancer cell line (HeLa), derived from human cervix adenocarcinoma, was 
purchase from ATCC (Manassas, VA, USA). HeLa cells were maintained in Eagle’s 
Minimum Essential Medium (EMEM) supplemented with 2 mM L-glutamine, 100 IU/mL 
penicillin/streptomycin, 1 mM sodium pyruvate, 10 mM hepes, 1.5 mg/L sodium 
bicarbonate and 10% fetal bovine serum (FBS).
Flow cytometry
To investigate cellular uptake of nanoparticles in HeLa cells, liposomal formulations were 
synthesized with the addition of Texas red-DOPE (Life Technologies, Carlsbad, CA) 
(Concentration 7 10−3 mg/mL; fluorescent lipid/total lipid molar ratio = 5/1000). Bare 
liposomes and liposome-HP complexes were administered to cells cultured with serum-free 
medium. HeLa cells were plated 200,000 cells/mL in 12-well dishes. After 24 hours, cells 
were incubated for 3 hours with 10 μg/mL of Texas res-labeled liposomes in serum-free 
Optimem medium. After the treatment cells were detached with trypsin/
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ethylenediaminetetraacetic acid (EDTA), washed two times with cold PBS, and run on a BD 
LSFORTESSA (BD Biosciences, San Jose, CA, USA). Cells were gated using forward vs 
side scatter to exclude debris. Data were analyzed using FlowJo software (FlowJo LLC data 
analysis software, Ashland, OR, USA).
Cell viability
To evaluate the potential toxicity arising from the administration of NPs, cell viability of 
HeLa cells was assessed by 3-(4,5-dymethyl thiazol 2-y1)-2,5-diphenyl tetrazolium bromide 
(MTT, mitochondrial respiration analysis; Sigma-Aldrich), according to Mosmann protocol. 
Briefly, HeLa cells were seeded on 96-wells plate (10,000 cells/well). The day after, cells 
were treated with 10 g/mL of each formulation in Optimem medium (Life Technologies, 
Carlsbad, CA) for 24 hours. Then, MTT was added to each well at the final concentration of 
0.5 mg/mL and after 4 hours of incubation at 37 °C, the formazan salt was dissolved with 
100 μL isopropylic alcohol. The absorbance of each well was measured with Glomax 
Discover System (Promega, Madison, WI, USA), a ready-to-use high performance 
multimode detection instrument.
Colocalization analysis
Fluorescence colocalization experiments were performed with an Olympus FV1000 
(Olympus, Tokyo, Japan) confocal microscope (objective: 60×, 1.40 NA, oil-immersion), 
equipped with an X-light spinning disk (pinhole aperture: 70 μm) and Lumencor Spectra X-
LED illumination. Hela cells were seeded onto 12 mm round glass coverlips and incubated 
for 1h in Optimem medium. MC liposomes and MC liposome-BC complexes were labeled 
with Texas red-DOPE (excitation/emission wavelengths: 595/615 nm). Lysosomes, clathrin, 
caveolae and macropinosomes were labeled with lysotracker, transferrin, cholera-toxin and 
dextran fluorescent dyes, respectively (excitation/emission wavelengths: 495/519 nm). 
Measurements of colocalization are based on the evaluation of Pearson’s and Manders 
coefficients46, 47 of dual-color fluorescence images, i.e. red (R) channel for complexes and 
green (G) channel for endocytic vesicles. The Pearson’s coefficient measures statistic 
correlation between the detected intensities of the two channels and is defined as
(1)
where Rk and Gk refer to the intensity values of the k-th pixel from red and green channel 
respectively and the brackets indicate averaging operations over the entire image48. P values 
range from 1 (i.e. perfect linear correlation) to -1 (anticorrelation). Values near zero reflect 
distributions that are not correlated with one another. Manders coefficients M1 and M2 
evaluate the overlap of the detected signals from the two channels. We carried out a pre-
processing procedure according to the Costes method48 to determine the threshold 
intensities, below which a pixel can be regarded as dark (i.e. with zero intensity). Thus, 
thresholds have been iteratively calculated and uniquely defined by the correlation of the raw 
channels. The Costes method is considered a robust and reproducible method that eliminates 
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user bias and can be easily automated 48. Finally, Manders coefficients have been obtained 
as46, 48:
(2)
where Rk′=Rk if Gk>0 and Rk′=0 if Gk=0 and
(3)
where Gk′=Gk if Rk>0 and Gk′=0 if Rk=0.
These split parameters quantify the percentage of not-dark pixels in both channels with 
respect to the total number of not-dark pixels in Channel R and Channel G, separately. 
Colocalization analyses were performed using Coloc2 plugin on ImageJ software (https://
imagej.nih.gov/ij/).
Measurements of intracellular dynamics
To study the intracellular dynamics of complexes, fluorescence microscopy experiments 
were performed with an Olympus FV1000 (Olympus, Tokyo, Japan) confocal microscope 
(objective: 100×, 1.40 NA, oil-immersion), provided with an X-light spinning disk (pinhole 
aperture: 70 μm) and Lumencor Spectra X-LED illumination. To study the intracellular 
dynamics of endocytic vesicles, fluorescence microscopy experiments were performed with 
an Olympus FluoView FV1000 confocal microscope with a 60× NA 1.20 water immersion 
objective. All experiments were carried out at 37 °C and 5% CO2 using an incubation 
chamber enclosing the microscope stage and body. The diameter of the detection pinhole 
was set to the size of 1 Airy. Sequential image series at 16 bits were collected at a fixed pixel 
size of 69 nm selecting a region of interest of 256×256 pixels and by varying the pixel dwell 
time from 0.5 to 2 or 4 μs per pixel depending on the characteristic diffusivity of the 
structure under study. The overall acquisition time varied from 30 to 60 seconds. Image-
stacks of at least 300 frames were collected at 1 Hz and the dynamics of about 7000 detected 
particles was determined by custom scripts working on MATLAB (MathWorks Inc., Natick, 
MA).
The processing is based on the iMSD method27,49, 50.
Protein Identification and quantification
MC liposomes (100 μL, concentration =1 mg/mL) were incubated with 100 μL of HP at 
37 °C. After 1-h incubation, liposome−BC complexes were centrifuged (14,000 rpm for 15 
min) to remove loosely bound proteins. Subsequently, pellets were washed three times with 
100 μL of the dissolving buffer (Tris-HCl pH 7.4, 10 mmol L−1; NaCl, 150 mmol L−1; 
EDTA, 1 mmol L−1). Protein denaturation, digestion, and desalting were carried out by a 
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robust methodology that is commonly used to separate liposome−BC complexes from 
unbound proteins51. Afterwards, lyophilization was performed by a Speed-Vac apparatus 
(mod. SC 250 Express; Thermo Savant, Holbrook, NY, USA). Then samples were 
reconstituted with 0.1% HCOOH solution (final concentration 0.32 mg/mL) and stored at 
− 80 °C until LC MS/MS was done. Tryptic peptides were examined by a nano-LC system 
(Dionex Ultimate 3000, Sunnyvale, CA, USA) connected to a hybrid mass spectrometer 
(Thermo Fisher Scientific Bremen, Germany), equipped with a nanoelectrospray ion source. 
Experimental details have been already reported.51 Xcalibur (v.2.07, ThermoFisher 
Scientific) raw data files were submitted to Proteome Discover (1.2 version, Thermo 
Scientific) for database search using Mascot (version 2.3.2 Matrix Science). Data were 
searched against SwissProt database (v 57.15, 20 266 sequences) using the decoy search 
option of Mascot. Finally, protein quantification was made by Scaffold software. For each 
identified protein, the mean value of (normalized spectral countings, NSCs) was normalized 
to the protein molecular weight (MWNSC) to obtain the relative protein abundance (RPA). 
Statistical significance of data was guaranteed by replicating the procedure for nine samples 
(three technical replicates for three independent biological samples). Data of relative protein 
abundance were provided as mean ± standard deviation.
Conclusions
We probe the role of BC in directing liposomes interaction with living cells. The switch 
from the synthetic identity (MC liposomes) to the biological one (MC liposomes with 
absorbed BC) is proved to be responsible for a switch in the uptake mechanism and 
intracellular trafficking properties of NPs, from macropinocytosis to clathrin-mediated 
endocytosis. Since Apolipoproteins are the main components of the BC, we suggest that this 
protein class may be active player in triggering receptor-mediated uptake of liposome-BC 
into HeLa cells. This finding sheds new light on the basic molecular determinants of NP 
interaction with living matter and, potentially, paves the way to a new era of studies aimed at 
creating targeted nanoformulations to exploit specific cellular pathways of interest. The 
knowledge obtained from this study will contribute to understand basic principles of the 
uptake mechanism. This will allow better prediction and control of the biodistribution of 
liposomes, which could lead to engineer such nanomaterials for specific targeting of tissues 
and/or organs of interest.
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Figure 1. 
Dual color fluorescence images of red-labeled liposomes, liposome-BC complexes and 
green-labeled endocytic vesicles corresponding to (A) Clathrin-mediated endocytosis 
(CME), (B) Caveolin-mediated endocytosis (CAV) CAV and (C) Macropinocytosis (MCR). 
(D, E, F) Measured values of Manders’ (M1, M2) and Pearson’s (P) coefficients as 
multivariate distributions and (G, H, I) corresponding 1D projections. Asterisks refer to 
Student’s t-test significance, in terms of p-values below (*) 0.01 and (**) 0.005
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Figure 2. 
Distributions of the measured dynamic parameters for liposomes and liposome-BC 
complexes (A) and (B) endocytic vesicles: clathrin-mediated endocytic vesicles (CME), 
caveolae (CAV) and micropinosomes (MCR). Corresponding weighted distributions of 
diffusion coefficient, D, and particle speed, v. Crosses indicate the distributions’ centroids.
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Figure 3. 
Histograms representing the Mahalanobis distances of data points corresponding to (A) 
liposomes and (B) liposome-BC complexes, from the distributions of clathrin-mediated 
endocytic vesicles (red), caveolae (green) and micropinosomes (blue).
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Figure 4. 
(A) Following exposure to plasma proteins, liposomes’ surface is decorated by a 
biomolecular corona (BC), which depends on several factors such liposome’ physiochemical 
properties (i.e. surface chemistry, size, charge etc.), protein source (e.g. human plasma vs. 
mouse plasma) and environmental factors (i.e. temperature, pH, etc.). To the sake of clarify, 
we underline that proteins cover liposome’ surface entirely, but, for simplicity of 
representation, we left the liposome surface only partly decorated by plasma proteins. (B) 
When particles are given to HeLa cells, they are efficiently internalized with cellular uptake 
being higher than 90% as quantified by flow cytometry. Despite similar levels of cellular 
uptake, BC promotes a neat switch of cell entry mechanism of liposomes, from 
macropinocytosis to clathrin-dependent endocytosis (C). BC has a major impact on the 
intracellular dynamics of liposomes. Our results highlight the crucial role of BC as an 
intrinsic trigger of specific NP-cell interactions and biological responses.
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Table 1
Preliminary characterization of the liposomes both in the absence (i.e. bare Liposomes) and in the presence of 
the biomolecular corona (BC) (i.e. Liposome-BC), in terms of average hydrodynamic diameter, Zeta potential, 
cell viability and uptake on HeLa cells.
Liposome Liposome-BC
Particle size (nm) 144±4 178±6
Zeta potential (mV) 34.5±1.1 −18±2
Cell viability (%) 99±1 89±5
Cell uptake (%) 98.9±0.3 92.8±2.3
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